David Hallal, CEO at ALEXION PHARMACEUTICALS INC (ALXN), sold 2,602 shares at $140.49 ($368K) on 2016-02-05, disclosed to the SEC on 2016-02-08.
Seasonal sale ($368k) by CEO — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $140.49 | 1,490 | $209K | 56.8% |
| 2 | $142.35 | 712 | $101K | 27.5% |
| 3 | $144.45 | 400 | $58K | 15.7% |
| Total | $141.61 avg | 2,602 | $368K | 100% |
| Filing → |
| ITOS | SELL | 2025-06-06 | $2.3M | — | Filing → |
| ALVR | SELL | 2022-10-21 | $5.1M | — | Filing → |
| ALVR | SELL | 2022-09-30 | $2.9M | — | Filing → |